| Literature DB >> 35956837 |
Oscar K Bitzer-Quintero1, Genaro G Ortiz2, Socorro Jaramillo-Bueno3, Elsy J Ramos-González4, María G Márquez-Rosales1, Daniela L C Delgado-Lara2,5, Erandis D Torres-Sánchez6, Aldo R Tejeda-Martínez1, Javier Ramirez-Jirano1.
Abstract
Psychoneuroendocrinoimmunology is the area of study of the intimate relationship between immune, physical, emotional, and psychological aspects. This new way of studying the human body and its diseases was initiated in the last century's first decades. However, the molecules that participate in the communication between the immune, endocrine, and neurological systems are still being discovered. This paper aims to describe the development of psychoneuroendocrinoimmunology, its scopes, limitations in actual medicine, and the extent of melatonin within it.Entities:
Keywords: endocrinology; immunology; melatonin; neurology; psychology
Mesh:
Substances:
Year: 2022 PMID: 35956837 PMCID: PMC9370109 DOI: 10.3390/molecules27154888
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Relationships among hypothalamic hormones, pituitary hormones, and target organs. Neurohypophysis secretion is controlled by nerve signals originating from the hypothalamus, unlike adenohypophysis secretion, which is controlled by hormones or releasing factors from the median eminence. Hormones released from the adenohypophysis are transported to their target organs through the bloodstream. Abbreviations: TRH—thyrotropin-releasing hormone; CRH—corticotropin-releasing hormone; GHRH—growth hormone-releasing hormone; GnRH—gonadotropin-releasing hormone; DA—dopamine; SST—somatostatin; GH—growth hormone; TSH—thyroid-stimulating hormone; ACTH—adrenocorticotropic hormone; LH—luteinizing hormone; FSH—follicle-stimulating hormone; ADH—antidiuretic hormone.
Figure 2General adaptation syndrome. The general adaptation syndrome is divided into three phases. In the presence of a stressor, phase 1 begins, where the body activates the hypothalamic-pituitary-adrenal axis with the consequent release of hormones to defend itself; in phase 2, symptoms are reduced, and anabolic functions are increased. Phase 3 is exhaustion.
Figure 3Opiates and cannabinoid system. The activation of the opiate system results in immunosuppression; in contrast, the cannabinoid system results in immunostimulation. Torres-Sanchez ED modified this image, which was obtained from Creative Commons BY based on an unknown author.
Figure 4The effect of pleasure on the sympathetic and parasympathetic response induces immunosuppression or immunostimulation, respectively. ED Torres-Sánchez modified this image, obtained from the Creative Commons BY base of an unknown author.
Abbreviations: MT1/MT2—receptor of melatonin 1/receptor of melatonin 2; ROR—retinoic acid receptor-related orphan receptor; COX-2—cyclooxygenase 2; iNOS—inducible nitric oxide synthase; NF-κB—nuclear factor kappa-light-chain-enhancer of activated B cells; STATs—signal transducer and activator of transcription; NLRP3—NLR family pyrin domain containing 3; α-KG—ketoglutarate alpha; ROS—reactive oxygen species; miR-155—micro RNA 155; miR34a—micro RNA 34a; miR23a—micro RNA 23a; miR27a—micro RNA 27a; miR24-2—micro RNA 24-2; IL-1β—interleukin 1 beta; IL-6—interleukin 6; CXCL8—C-X-C motif chemokine ligand 8; CCL2—C-C motif chemokine ligand 2; CCL4—C-C motif chemokine ligand 4; MMP9—matrix metalloproteinase 9; MAPK—mitogen-activated protein kinase; Akt—protein kinase B; TNF-α—tumor necrosis factor alpha; IL-8—interleukin 8; ERK—extracellular signal-regulated kinase; IL-2—interleukin 2; IL-4—interleukin 4; INF-γ—interferon gamma; CD62L—cluster of differentiation 62 ligand; CD8+—cluster of differentiation 8 positive on T cell; AC—adenylyl cyclase; PKA—protein kinase A; PLC—phospholipase C; PKC—protein kinase C; MHC-II—major histocompatibility complex class II; TLR3—toll receptor 3; p38 MAP—p38 mitogen-activated protein kinases; JNK—c-Jun N-terminal kinase; CD95—cluster of differentiation 95; IL-12—interleukin 12.
| Immune Cell | Effects of Melatonin | References |
|---|---|---|
| Innate System | ||
| Monocyte | Activates cells through PKC | [ |
| Increases the number of cells | [ | |
| Induces ROS production | [ | |
| Induces the cytokine production: IL-1, IL-6, TNF-α | [ | |
| Attenuates binding activity | [ | |
| Macrophage | Influences the phenotype polarization | [ |
| Preventes COX-2 and iNOS activation | [ | |
| Regulates signaling pathways: NF-κB, STATs, NLRP3/ caspase-1 | [ | |
| Regulates cellular metabolic pathways: α-KG, ROS | [ | |
| Mitochondrial dynamics and mitophagy | [ | |
| Regulates the expression of miRNAs: miR-155, miR34a, miR23a, miR27a, miR24-2 | [ | |
| Expression of cytokines: IL-1b, IL-6 | [ | |
| Could synthesize melatonin | [ | |
| Dendritic cell | Increases the secretory activity through raised endosomal compartments | [ |
| Increases in the number of cells and diameter | [ | |
| Could synthesize melatonin | [ | |
| Neutrophil | Protects neutrophils from oxidative stress-induced apoptosis | [ |
| Reduces ROS generation | [ | |
| Restores their functions: phagocytosis, degranulation, NETosis | [ | |
| Suppresses the release of CXCL8, CCL2, CCL4, and MMP9 by blockage of p38 MAPK and Akt signaling | [ | |
| Suppresses the release of cytokines: TNF-a, IL-8 | [ | |
| Modulates the migration through the endothelial layer by blocking the ERK phosphorylation signal | [ | |
| Reduces the microbicidal activity | [ | |
| Eosinophil | Suppresses eosinophils activity | [ |
| Decreases eosinophil number | [ | |
| Mast cell | Avoid degranulation | [ |
| Regulates differentiation and cellular proliferation | [ | |
| Restores circadian rhythms | [ | |
| Reduces the cytotoxicity | [ | |
| Inhibits the expression of proinflammatory cytokines and COX2 | [ | |
| Could synthesize melatonin | [ | |
| Adaptative system | ||
| T cell | Decrease migration | [ |
| Release cytokines: IL-2, IL-4, IL-6, INF-g | [ | |
| Promotes the balance in subpopulations T cell-mediated immune responses | [ | |
| Regulates the levels of surface CD62L on CD8+ cells | [ | |
| Regulates cell proliferation by AC/ PKA and PLC/ PKC pathways | [ | |
| Enhances antigen presentation by macrophages to T cells by increasing the expression of MHC-II | [ | |
| Inhibits the expression of TLR3, p38 MAP, JNK, and MAPK/ NF-κ B pathways | [ | |
| Regulates the expression of CD95 ligand | [ | |
| B cell | Induces the cellular activation | [ |
| Promotes the cell proliferation | [ | |
| Promotes the antibody production | [ | |
| Represses 5-lipoxygenase gene | [ | |
| Natural killer | Increases the number of cells | [ |
| Promotes the expression of cytokines: IL-2, IL-12, IL-6, INF-g | [ | |
| Modulates cell activity | [ | |
| Regulates the levels of surface CD62L | [ |
Figure 5MLT is synthesized in the pineal gland. It has proinflammatory and anti-inflammatory effects and multiple functions, among which the adaptive immune response stands out. ED Torres-Sánchez modified this image, obtained from the Creative Commons BY base of an unknown author.
Figure 6Effects of melatonin in major depressive disorder and cognitive impairments. The pathological process of neurological diseases involves an increase in oxidative stress and an increase in proinflammatory cytokines that stimulate astrocytes and activate microglia. In contrast, by interacting with M2 receptors, melatonin decreases oxidative stress and neuroinflammation. ED Torres-Sánchez modified this image, obtained from the Creative Commons BY base of an unknown author and QIAGEN’s original.